A Study, Comparing a Dose-Titration Regimen of Fulvestrant With the Approved Dosing Regimen in Postmenopausal Patients With Hormone-Responsive Advanced Breast Cancer (ABC)

NCT00927511 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
104
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Regina Elena Cancer Institute

Collaborators